CARTEOLOL HYDROCHLORIDE (Bausch & Lomb Incorporated)


Welcome to the PulseAid listing for the CARTEOLOL HYDROCHLORIDE drug offered from Bausch & Lomb Incorporated. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Bausch & Lomb Incorporated
NON-PROPRIETARY NAME: CARTEOLOL HYDROCHLORIDE
SUBSTANCE NAME: CARTEOLOL HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2000-01-20
END MARKETING DATE: 0000-00-00


CARTEOLOL HYDROCHLORIDE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCARTEOLOL HYDROCHLORIDE from Bausch & Lomb Incorporated
LABELER NAME: Bausch & Lomb Incorporated
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2000-01-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 24208-367_daabd401-9354-4153-bbb1-03457739dd63
PRODUCT NDC: 24208-367
APPLICATION NUMBER: ANDA075546

Other CARTEOLOL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Bausch & Lomb IncorporatedCARTEOLOL HYDROCHLORIDE
Medsource PharmaceuticalsCARTEOLOL HYDROCHLORIDE
Sandoz Inc.Carteolol Hydrochloride